Potential Role of Magnesium and Uric Acid in Metabolic Syndrome
Authors/Creators
- 1. PhD Research Scholar, Department of Biochemistry, Index Medical College, Indore
- 2. Associate Professor, Department of Biochemistry, Index Medical College, Indore
- 3. Assistant Professor, Department of Biochemistry, Index Medical College, Indore
- 4. Associate Professor, Department of Biochemistry, Jhalawar Medical College, Jhalawar, Rajasthan
Description
Introduction: Metabolic syndrome is a well-recognized risk factor for cardiovascular diseases. It is associated with various disorders such as overweight and obesity, insulin resistance, type 2 diabetes mellitus and hypertension. Magnesium is an essential nutrient for maintaining vital physiological functions. Hypomagnesaemia may be implicated in the pathogenesis of various metabolic disorders such as overweight and obesity, insulin resistance, type 2 diabetes mellitus and hypertension. Hyperuricemia reflects defect in insulin action on the renal tubular reabsorption of uric acid in the renal system and may contribute to hypertension through its effect on the endothelium in the blood vessels. Objectives: To evaluate the role of serum Magnesium and Uric acid level in patients with metabolic syndrome. Methodology: We conducted an analytical case-control study on Metabolic Syndrome patients (N=90) and age matched healthy controls (N=90). Serum magnesium and Uric acid level were measured by colorimetric and Uricase-PAP method respectively. Results: We found that serum Magnesium levels were significantly decreased (0.8 ± 0.4 Mg/dl) in patients having metabolic syndrome as compared to healthy controls 2.0 ± 0.2 Mg/dl), whereas there were elevated levels of serum uric acid (10.5± 2.5 Mg/dl) in metabolic syndrome patients as compared to healthy controls (6.5 ±2.5 Mg/dl). Conclusions: Low serum magnesium levels have been associated with risk factors of metabolic syndrome, such as hyperglycemia, hypertension, hypertriglyceridemia and insulin resistance. Increased serum uric acid levels are commonly seen in patients with metabolic syndrome and are widely accepted as risk factors for hypertension and cardiovascular diseases.
Abstract (English)
Introduction: Metabolic syndrome is a well-recognized risk factor for cardiovascular diseases. It is associated with various disorders such as overweight and obesity, insulin resistance, type 2 diabetes mellitus and hypertension. Magnesium is an essential nutrient for maintaining vital physiological functions. Hypomagnesaemia may be implicated in the pathogenesis of various metabolic disorders such as overweight and obesity, insulin resistance, type 2 diabetes mellitus and hypertension. Hyperuricemia reflects defect in insulin action on the renal tubular reabsorption of uric acid in the renal system and may contribute to hypertension through its effect on the endothelium in the blood vessels. Objectives: To evaluate the role of serum Magnesium and Uric acid level in patients with metabolic syndrome. Methodology: We conducted an analytical case-control study on Metabolic Syndrome patients (N=90) and age matched healthy controls (N=90). Serum magnesium and Uric acid level were measured by colorimetric and Uricase-PAP method respectively. Results: We found that serum Magnesium levels were significantly decreased (0.8 ± 0.4 Mg/dl) in patients having metabolic syndrome as compared to healthy controls 2.0 ± 0.2 Mg/dl), whereas there were elevated levels of serum uric acid (10.5± 2.5 Mg/dl) in metabolic syndrome patients as compared to healthy controls (6.5 ±2.5 Mg/dl). Conclusions: Low serum magnesium levels have been associated with risk factors of metabolic syndrome, such as hyperglycemia, hypertension, hypertriglyceridemia and insulin resistance. Increased serum uric acid levels are commonly seen in patients with metabolic syndrome and are widely accepted as risk factors for hypertension and cardiovascular diseases.
Files
IJPCR,Vol15,Issue10,Article56.pdf
Files
(341.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:889237e3d6944bdcd566cdc97b5e0ba3
|
341.6 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-09-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue10,Article56.pdf
- Development Status
- Active
References
- 1. Pelczyńska M, Moszak M, Bogdański P. The Role of Magnesium in the Pathogenesis of Metabolic Disorders. Nutrients. 2022 Apr 20; 14(9):1714-1719. 2. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:1739 –1742 3. Quinones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995; 268: E1–E5. 4. Fox IH. Metabolic basis for disorders of purine nucleotide degradation. Metabolism 1981; 30:616–634. 5. Seong Kyu Kim Interrelationship of Uric Acid, Gout, and Metabolic Syndrome: Focus on Hypertension, Cardiovascular Disease, and Insulin Resistance. Journal of Rheumatic Diseases 2018, 25 (1):19-27 6. Liberopoulos EN, Miltiadous GA, Elisaf MS. Alcohol intake, serum uric acid concentrations, and risk of gout. Lancet 2004; 364:246–247. 7. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002; 25:1790 –1794. 8. Ka He, ScD; Kiang Liu, Martha L. Daviglus, Steven J. Morris, Catherine M. Loria, Linda Van Horn, David R. Jacobs, Jr, Peter J. Savage, Magnesium Intake and Incidence of Metabolic Syndrome Among Young Adults. Circulation 20061675-16829. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY, Kim SW, Ryu SH, Keum DG. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69: 928– 933. 10. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 2006; 55:1293–1301. 11. YokokawaH, FukudaH, Suzuki A, et al. Association between serum uric acid levels/hyperuricemia and hypertension among 85,286 Japanese workers. J Clin Hypertens2016; 18:53–9. 12. Wei F, Sun N, Cai C, et al. Associations between serum uric acid and the incidence of hypertension: a Chinese senior dynamic cohort study. J Transl Med 2016; 14:110. 13. Li LX, Dong XH, Li MF, et al. Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese in patients with type 2 diabetes. J Hypertens2015; 33:482–90. 14. Prasad M, Matteson EL, Herrmann J, et al. Uric acid is associated with inflammation, coronary microvascular dysfunction, and adverse outcomes in postmenopausal women. Hypertension 2017; 69:236–42. 15. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. NEngl J Med 2008; 359:1811–21. 16. Gerd Assmann, Helmut Schulte the Prospective Cardiovascular Münster (PROCAM) study: Prevalence of hyperlipidaemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. AHJ vol116; December 1988, Pages 1713-1724. 17. Gozdearitici, Murat Bas. Metabolic syndrome and calcium: The effects on body composition and biochemical parameters among premenopausal women. Progress in nutrition 2018; vol.20, N.2:220-228. 18. Piuri G, Zocchi M, Della Porta M, Ficara V, Manoni M, Zuccotti GV, Pinotti L, Maier JA, Cazzola R. Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes. Nutrients. 2021 Jan 22; 13(2):320. 19. Ali M. Zaakouk, Mohammed A. Hassan, Omar A. Tolba. Serum magnesium status among obese children and adolescents. Egyptian Paediatric Journal 2016; 64 (1): 32-37.